688273 麦澜德
交易中 12-18 10:48:40
资讯
新帖
简况
麦澜德:12月11日接受机构调研,华安证券、承鑫投资等多家机构参与
证券之星 · 12-12
麦澜德:12月11日接受机构调研,华安证券、承鑫投资等多家机构参与
麦澜德(688273)新增【AI智能体】概念
证券之星 · 12-08
麦澜德(688273)新增【AI智能体】概念
麦澜德:高管陈江宁减持计划届满未减持
证券日报 · 12-07
麦澜德:高管陈江宁减持计划届满未减持
麦澜德(688273)披露高级管理人员减持计划时间届满暨减持股份结果公告,12月05日股价上涨1.27%
证券之星 · 12-05
麦澜德(688273)披露高级管理人员减持计划时间届满暨减持股份结果公告,12月05日股价上涨1.27%
11月25日麦澜德涨5.12%,金元顺安成长动力混合基金重仓该股
证券之星 · 11-25
11月25日麦澜德涨5.12%,金元顺安成长动力混合基金重仓该股
【机构调研记录】同泰基金调研麦澜德
证券之星 · 11-25
【机构调研记录】同泰基金调研麦澜德
【私募调研记录】青骊投资调研麦澜德
证券之星 · 11-25
【私募调研记录】青骊投资调研麦澜德
麦澜德(688273)披露2025年前三季度权益分派实施公告,11月20日股价下跌0.45%
证券之星 · 11-20
麦澜德(688273)披露2025年前三季度权益分派实施公告,11月20日股价下跌0.45%
每周股票复盘:麦澜德(688273)2025年前三季度拟分红
证券之星 · 11-09
每周股票复盘:麦澜德(688273)2025年前三季度拟分红
麦澜德(688273)披露2025年前三季度利润分配方案,11月07日股价下跌2.48%
证券之星 · 11-07
麦澜德(688273)披露2025年前三季度利润分配方案,11月07日股价下跌2.48%
麦澜德新注册《营养与健康管理软件V1.0》项目的软件著作权
证券之星 · 11-05
麦澜德新注册《营养与健康管理软件V1.0》项目的软件著作权
每周股票复盘:麦澜德(688273)拟每10股派现3.00元
证券之星 · 11-02
每周股票复盘:麦澜德(688273)拟每10股派现3.00元
麦澜德(688273)披露2025年前三季度利润分配方案,10月31日股价上涨1.47%
证券之星 · 10-31
麦澜德(688273)披露2025年前三季度利润分配方案,10月31日股价上涨1.47%
麦澜德新注册《人体成分分析软件V1.0》项目的软件著作权
证券之星 · 10-31
麦澜德新注册《人体成分分析软件V1.0》项目的软件著作权
每周股票复盘:麦澜德(688273)Q3净利增36.71%,股东户数增17.23%
证券之星 · 10-26
每周股票复盘:麦澜德(688273)Q3净利增36.71%,股东户数增17.23%
麦澜德(688273)2025年三季报简析:增收不增利
证券之星 · 10-24
麦澜德(688273)2025年三季报简析:增收不增利
麦澜德(688273.SH)发布前三季度业绩,归母净利润9599.87万元,同比下降0.07%
智通财经 · 10-22
麦澜德(688273.SH)发布前三季度业绩,归母净利润9599.87万元,同比下降0.07%
每周股票复盘:麦澜德(688273)H1净利降11.96%,拟取消监事会
证券之星 · 09-14
每周股票复盘:麦澜德(688273)H1净利降11.96%,拟取消监事会
麦澜德涨5.13%,华源证券一周前给出“买入”评级
中金财经 · 09-10
麦澜德涨5.13%,华源证券一周前给出“买入”评级
麦澜德(688273.SH):在脑机接口领域,公司聚焦非侵入式脑机接口方向
格隆汇 · 09-08
麦澜德(688273.SH):在脑机接口领域,公司聚焦非侵入式脑机接口方向
加载更多
公司概况
公司名称:
南京麦澜德医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2022-08-11
主营业务:
南京麦澜德医疗科技股份有限公司的主营业务是盆底及妇产康复领域相关医疗器械产品的研发、生产、销售和服务。公司的主要产品是生物刺激反馈仪、彩色超声诊断评估系统、磁刺激仪、高频评估电灼仪、盆底训练仪、便携式产后恢复仪、家用盆底康复治疗仪、3D皮肤分析仪、便携式手持测肤仪、手持镜系统、CO2激光治疗仪、Nd:YAG皮秒激光治疗仪、红蓝光皮肤治疗仪、强脉冲光治疗仪、手指关节康复评估系统、便携式手功能康复评估系统、手功能磁刺激系统、经颅磁刺激系统、生物刺激反馈仪、便携式生物刺激反馈仪、阴道电极、直肠电极、阴道探头。公司高度重视知识产权保护,将其视为企业核心竞争力的重要组成部分。公司通过长期的技术研发投入和自主创新,积累了丰富的知识产权成果,包括219条商标信息和209条专利信息。
发行价格:
40.29
{"stockData":{"symbol":"688273","market":"SH","secType":"STK","nameCN":"麦澜德","latestPrice":34.95,"timestamp":1766026120000,"preClose":34.43,"halted":0,"volume":418652,"delay":0,"changeRate":0.0151,"floatShares":36826800,"shares":100000000,"eps":1.0151,"marketStatus":"交易中","change":0.52,"latestTime":"12-18 10:48:40","open":34.3,"high":35.25,"low":34.27,"amount":14614800,"amplitude":0.0285,"askPrice":34.94,"askSize":4,"bidPrice":34.91,"bidSize":6,"shortable":0,"etf":0,"ttmEps":1.0151,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766028600000},"marketStatusCode":2,"adr":0,"adjPreClose":34.43,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":37.87,"lowLimit":30.99,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":100000000,"isCdr":false,"pbRate":2.52,"roa":"--","peRate":34.430105,"roe":"7.13%","epsLYR":1.0309,"committee":0.403509,"marketValue":3495000000,"turnoverRate":0.0114,"status":0,"floatMarketCap":1287000000},"requestUrl":"/m/hq/s/688273","defaultTab":"news","newsList":[{"id":"2590054945","title":"麦澜德:12月11日接受机构调研,华安证券、承鑫投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2590054945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590054945?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:04","pubTimestamp":1765541048,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年12月12日麦澜德发布公告称公司于2025年12月11日接受机构调研,华安证券、承鑫投资、瑞华控股投资、首创证券、潼骁投资、银创资本参与。公司目前已在国内多省市头部妇幼保健院启动抗衰中心试点建设,并联合中国妇幼保健协会参与制定相关行业建设标准。该股最近90天内共有2家机构给出评级,买入评级2家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200035760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0201","BK0183","688273","BK0276","600909"],"gpt_icon":0},{"id":"2589635887","title":"麦澜德(688273)新增【AI智能体】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2589635887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589635887?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197019,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,12月8日麦澜德新增概念。该公司关联的其它概念板块还包括:人工智能、机器人概念、DeepSeek概念、医美概念、辅助生殖、婴童概念。麦澜德主营业务:从事盆底及产后康复领域相关产品的研发、生产、销售和服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800030929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273","159819"],"gpt_icon":0},{"id":"2589607870","title":"麦澜德:高管陈江宁减持计划届满未减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2589607870","media":"证券日报 ","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589607870?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:36","pubTimestamp":1765110960,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月5日晚间,麦澜德发布公告称,公司于近日收到陈江宁女士出具的《股份减持结果告知函》,获悉其在2025年9月5日至2025年12月4日期间未减持公司股票,本次减持计划时间已届满。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswf2607508.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswf2607508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2589813549","title":"麦澜德(688273)披露高级管理人员减持计划时间届满暨减持股份结果公告,12月05日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589813549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589813549?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:24","pubTimestamp":1764944669,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘,麦澜德报收于35.19元,较前一交易日上涨1.27%,最新总市值为35.19亿元。该股当日开盘34.94元,最高35.73元,最低34.46元,成交额达2867.92万元,换手率为2.21%。根据2025年8月15日披露的减持计划,陈江宁拟在2025年9月5日至12月4日期间通过集中竞价或大宗交易方式减持不超过259,815股,占公司总股本不超过0.26%。截至减持计划期限届满,陈江宁未减持公司股份,仍持有1,039,261股,持股比例不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2586004442","title":"11月25日麦澜德涨5.12%,金元顺安成长动力混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586004442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586004442?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:33","pubTimestamp":1764056031,"startTime":"0","endTime":"0","summary":"证券之星消息,11月25日麦澜德涨5.12%,收盘报35.73元,换手率4.39%,成交量1.62万手,成交额5734.58万元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为金元顺安基金的金元顺安成长动力混合。孔祥鹏在任的基金产品包括:金元顺安宝石动力混合,管理时间为2020年12月22日至今,期间收益率为-12.81%;金元顺安价值增长混合,管理时间为2022年4月28日至今,期间收益率为-12.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500017364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2586419630","title":"【机构调研记录】同泰基金调研麦澜德","url":"https://stock-news.laohu8.com/highlight/detail?id=2586419630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586419630?lang=zh_cn&edition=full","pubTime":"2025-11-25 08:04","pubTimestamp":1764029082,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月24日披露的机构调研信息,同泰基金近期对1家上市公司进行了调研,相关名单如下:1)麦澜德 调研纪要:公司依托国家重点研发计划项目,在认知功能障碍干预、运动功能障碍康复及精神与心身疾病调控三大方向推进非侵入式脑机接口技术。同泰基金成立于2018年,截至目前,资产管理规模47.28亿元,排名156/211;资产管理规模47.26亿元,排名136/211;管理公募基金数48只,排名107/211;旗下公募基金经理6人,排名135/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500003757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2586041961","title":"【私募调研记录】青骊投资调研麦澜德","url":"https://stock-news.laohu8.com/highlight/detail?id=2586041961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586041961?lang=zh_cn&edition=full","pubTime":"2025-11-25 08:03","pubTimestamp":1764029032,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月24日披露的机构调研信息,知名私募青骊投资近期对1家上市公司进行了调研,相关名单如下:1)麦澜德 调研纪要:公司依托国家重点研发计划项目,在认知功能障碍干预、运动功能障碍康复及精神与心身疾病调控三大方向推进非侵入式脑机接口技术。机构简介:青骊投资管理(上海)有限公司成立于2015年4月,注册资金1000万元,具有基金业协会私募投资基金管理人资格,主要从事证券投资及股权投资的管理与咨询业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025112500003723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2584130295","title":"麦澜德(688273)披露2025年前三季度权益分派实施公告,11月20日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584130295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584130295?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:30","pubTimestamp":1763649055,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘,麦澜德报收于35.23元,较前一交易日下跌0.45%,最新总市值为35.23亿元。该股当日开盘35.48元,最高35.74元,最低35.08元,成交额达1608.36万元,换手率为1.24%。公司近日发布《2025年前三季度权益分派实施公告》,宣布本次利润分配方案为每股派发现金红利0.3元(含税)。股权登记日为2025年11月26日,除权(息)日和现金红利发放日均为2025年11月27日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2582861578","title":"每周股票复盘:麦澜德(688273)2025年前三季度拟分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861578?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:42","pubTimestamp":1762630935,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,麦澜德报收于38.18元,较上周的41.4元下跌7.78%。本周,麦澜德11月3日盘中最高价报41.87元。本周关注点公司公告汇总:麦澜德2025年第三次临时股东会审议通过前三季度利润分配方案。公司公告汇总北京市中伦律师事务所出具法律意见书,确认南京麦澜德医疗科技股份有限公司2025年第三次临时股东会的召集、召开程序,召集人资格,出席会议人员资格,表决程序及表决结果均符合相关法律法规及公司章程的规定,会议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2581889798","title":"麦澜德(688273)披露2025年前三季度利润分配方案,11月07日股价下跌2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581889798","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581889798?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:29","pubTimestamp":1762525764,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,麦澜德报收于38.18元,较前一交易日下跌2.48%,最新总市值为38.18亿元。该股当日开盘38.91元,最高39.3元,最低38.11元,成交额达4211.32万元,换手率为2.98%。公司近日发布公告,称于2025年11月7日召开2025年第三次临时股东会,审议通过《关于2025年前三季度利润分配方案的议案》和《关于变更公司注册地址、修订<公司章程>并办理工商变更登记的议案》。北京市中伦律师事务所对本次会议出具法律意见书,确认会议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700039269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2581904711","title":"麦澜德新注册《营养与健康管理软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2581904711","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581904711?lang=zh_cn&edition=full","pubTime":"2025-11-05 13:05","pubTimestamp":1762319127,"startTime":"0","endTime":"0","summary":"证券之星消息,近日麦澜德新注册了《营养与健康管理软件V1.0》项目的软件著作权。今年以来麦澜德新注册软件著作权6个,较去年同期增加了500%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了2826.5万元,同比增6.99%。通过天眼查大数据分析,南京麦澜德医疗科技股份有限公司共对外投资了17家企业,参与招投标项目948次;财产线索方面有商标信息267条,专利信息277条,著作权信息48条;此外企业还拥有行政许可388个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500017966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2580403971","title":"每周股票复盘:麦澜德(688273)拟每10股派现3.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580403971","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580403971?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:48","pubTimestamp":1762048094,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,麦澜德报收于41.4元,较上周的41.92元下跌1.24%。本周,麦澜德10月27日盘中最高价报42.99元。本周关注点公司公告汇总:拟向全体股东每10股派发现金红利3.00元(含税)公司公告汇总:拟变更公司注册地址至南京市江宁区华林路1号公司公告汇总:2025年第三次临时股东会将于2025年11月7日召开公司公告汇总南京麦澜德医疗科技股份有限公司2025年第三次临时股东会会议将于2025年11月7日召开,审议两项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2579457037","title":"麦澜德(688273)披露2025年前三季度利润分配方案,10月31日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579457037","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579457037?lang=zh_cn&edition=full","pubTime":"2025-10-31 18:27","pubTimestamp":1761906442,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,麦澜德报收于41.4元,较前一交易日上涨1.47%,最新总市值为41.4亿元。该股当日开盘40.69元,最高42.28元,最低40.69元,成交额达5456.18万元,换手率为3.58%。公司近日发布公告,将于2025年11月7日召开2025年第三次临时股东会会议,审议包括2025年前三季度利润分配方案在内的两项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100039859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2579173348","title":"麦澜德新注册《人体成分分析软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2579173348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579173348?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:04","pubTimestamp":1761847465,"startTime":"0","endTime":"0","summary":"证券之星消息,近日麦澜德(688273)新注册了《人体成分分析软件V1.0》项目的软件著作权。今年以来麦澜德新注册软件著作权5个,较去年同期增加了400%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了2826.5万元,同比增6.99%。通过天眼查大数据分析,南京麦澜德医疗科技股份有限公司共对外投资了17家企业,参与招投标项目937次;财产线索方面有商标信息267条,专利信息277条,著作权信息48条;此外企业还拥有行政许可387个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100002734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2578668507","title":"每周股票复盘:麦澜德(688273)Q3净利增36.71%,股东户数增17.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578668507","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578668507?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:42","pubTimestamp":1761421333,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,麦澜德报收于41.92元,较上周的40.62元上涨3.2%。本周,麦澜德10月20日盘中最高价报42.88元。麦澜德当前最新总市值41.92亿元,在医疗器械板块市值排名86/126,在两市A股市值排名3762/5160。第三季度单季净利润同比增长36.71%,主要因政府补助增加。募投项目包括麦澜德总部生产基地建设、研发中心建设和营销服务及信息化建设项目,原定于2025年12月29日达到预定可使用状态,现延期至2026年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2577153730","title":"麦澜德(688273)2025年三季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2577153730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577153730?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:02","pubTimestamp":1761256967,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期麦澜德发布2025年三季报。根据财报显示,麦澜德增收不增利。截至本报告期末,公司营业总收入3.44亿元,同比上升4.01%,归母净利润9599.87万元,同比下降0.07%。按单季度数据看,第三季度营业总收入1.03亿元,同比上升0.42%,第三季度归母净利润3207.86万元,同比上升36.71%。本次财报公布的各项数据指标表现一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688273"],"gpt_icon":0},{"id":"2577351593","title":"麦澜德(688273.SH)发布前三季度业绩,归母净利润9599.87万元,同比下降0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577351593","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577351593?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:57","pubTimestamp":1761123474,"startTime":"0","endTime":"0","summary":"智通财经APP讯,麦澜德(688273.SH)披露2025年第三季度报告,公司前三季度实现营收3.44亿元,同比增长4.01%;归属于上市公司股东的净利润9599.87万元,同比下降0.07%;扣非净利润7980万元,同比下降9.74%;基本每股收益0.9813元。公司拟向全体股东每10股派发现金红利人民币3.00元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688273"],"gpt_icon":0},{"id":"2567347139","title":"每周股票复盘:麦澜德(688273)H1净利降11.96%,拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2567347139","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567347139?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:45","pubTimestamp":1757799917,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,麦澜德报收于40.3元,较上周的39.71元上涨1.49%。本周,麦澜德9月12日盘中最高价报41.39元。本周关注点公司公告汇总:麦澜德2025上半年净利润同比下降11.96%。麦澜德2025年第二次临时股东大会决议公告显示,会议由董事会召集,董事长杨瑞嘉主持,表决方式合法有效。出席会议股东53人,代表有表决权股份61,352,970股,占公司总股本的62.7280%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688273","BK0251"],"gpt_icon":0},{"id":"2566676770","title":"麦澜德涨5.13%,华源证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2566676770","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566676770?lang=zh_cn&edition=full","pubTime":"2025-09-10 16:29","pubTimestamp":1757492960,"startTime":"0","endTime":"0","summary":"今日麦澜德涨5.13%,收盘报41.19元。2025年8月30日,华源证券研究员刘闯,林海霖发布了对麦澜德的研报《生殖康复快速增长,积极布局潜力业务》,该研报对麦澜德给出“买入”评级。基于公司在盆底康复领域产品处于领先位置,康复产线多元化布局,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为华源证券的刘闯。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202509/10/20250910654267.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202509/10/20250910654267.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20250910/31630881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688273","161027"],"gpt_icon":0},{"id":"2565688736","title":"麦澜德(688273.SH):在脑机接口领域,公司聚焦非侵入式脑机接口方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2565688736","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565688736?lang=zh_cn&edition=full","pubTime":"2025-09-08 18:32","pubTimestamp":1757327566,"startTime":"0","endTime":"0","summary":"格隆汇9月8日丨麦澜德在投资者互动平台表示,在人工智能领域,1)公司持续深化AI在盆底康复领域的应用。在脑机接口领域,公司聚焦非侵入式脑机接口方向,目前已在上肢和手部运动机器人、无创神经调控、多模态生理信号采集等领域形成技术积累。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/08183253000025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688273","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766026127563,"stockEarnings":[{"period":"1week","weight":-0.014},{"period":"1month","weight":-0.0488},{"period":"3month","weight":-0.1281},{"period":"6month","weight":0.2994},{"period":"1year","weight":0.4156},{"period":"ytd","weight":0.5065}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京麦澜德医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6402人(较上一季度增加17.23%)","perCapita":"5752股","listingDate":"2022-08-11","address":"江苏省南京市江宁区乾德路6号5幢二层(江宁高新园)","registeredCapital":"10000万元","survey":" 南京麦澜德医疗科技股份有限公司的主营业务是盆底及妇产康复领域相关医疗器械产品的研发、生产、销售和服务。公司的主要产品是生物刺激反馈仪、彩色超声诊断评估系统、磁刺激仪、高频评估电灼仪、盆底训练仪、便携式产后恢复仪、家用盆底康复治疗仪、3D皮肤分析仪、便携式手持测肤仪、手持镜系统、CO2激光治疗仪、Nd:YAG皮秒激光治疗仪、红蓝光皮肤治疗仪、强脉冲光治疗仪、手指关节康复评估系统、便携式手功能康复评估系统、手功能磁刺激系统、经颅磁刺激系统、生物刺激反馈仪、便携式生物刺激反馈仪、阴道电极、直肠电极、阴道探头。公司高度重视知识产权保护,将其视为企业核心竞争力的重要组成部分。公司通过长期的技术研发投入和自主创新,积累了丰富的知识产权成果,包括219条商标信息和209条专利信息。","listedPrice":40.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦澜德(688273)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦澜德(688273)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦澜德,688273,麦澜德股票,麦澜德股票老虎,麦澜德股票老虎国际,麦澜德行情,麦澜德股票行情,麦澜德股价,麦澜德股市,麦澜德股票价格,麦澜德股票交易,麦澜德股票购买,麦澜德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦澜德(688273)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦澜德(688273)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}